We now have 46 MRIdian systems installed and over 50 in backlog. Our mission is to treat improve what others can't. If you're not on the webcast, I'll be referring to slides from the presentation on our Investor Relations site. Zach will cover our financial results, and then we look forward to answering your questions. Today, we will begin with key patient metrics, then discuss our third quarter results and recent events We'll share exciting progress in our clinical and innovation pipelines. Good afternoon, everyone, and welcome to our Q3 call. Scott Drake - President and Chief Executive Officer

ViewRay undertakes no obligation to revise or otherwise update any statements to reflect events or circumstances after the date of this call. Furthermore, the content of this conference call contains time-sensitive information accurate only as of today, November 4, 2021. For a description of these risks and uncertainties, please see ViewRay annual report on Form 10-K for the fiscal year ended December 31, 2020, and in its quarterly reports on Form 10-Q as updated periodically with the company's other SEC filings.

Vray price